Predictors of cerebrovascular events and death among patients with valvular heart disease: A population-based study
- PMID: 11062286
- DOI: 10.1161/01.str.31.11.2628
Predictors of cerebrovascular events and death among patients with valvular heart disease: A population-based study
Abstract
Background and purpose: There is little population-based information on cerebrovascular events and survival among valvular heart disease patients. We used the Kaplan-Meier product-limit method and the Cox proportional hazards model to determine rates and predictors of cerebrovascular events and death among valve disease patients.
Methods: This population-based historical cohort study in Olmsted County, Minnesota, reviewed residents with a first echocardiographic diagnosis of mitral stenosis (n=19), mitral regurgitation (n=528), aortic stenosis (n=140), and aortic regurgitation (n=106) between 1985 and 1992.
Results: During 2694 person-years of follow-up, 98 patients developed cerebrovascular events and 356 died. Compared with expected numbers, these observations are significantly elevated, with standardized morbidity ratio of 3.2 (95% CI, 2.6 to 3.8) and 2. 5 (95% CI, 2.2 to 2.7), respectively. Independent predictors of cerebrovascular events were age, atrial fibrillation, and severe aortic stenosis. The risk ratio of severe aortic stenosis was 3.5 (95% CI, 1.4 to 8.6), with atrial fibrillation conferring greater risk at younger age. Predictors of death were age, sex, cerebrovascular events, ischemic heart disease, and congestive heart failure, the greatest risk being among those with both congestive heart failure and cerebrovascular events (risk ratio=8.8; 95% CI, 5. 8 to 13.4). Valve disease type and severity were not independent determinants of death.
Conclusions: The risk of cerebrovascular events and death among patients with valve disease remains high. Age, atrial fibrillation, and severe aortic stenosis are independent predictors of cerebrovascular events, and age, sex, cerebrovascular events, congestive heart failure, and ischemic heart disease are independent predictors of death in these patients.
Similar articles
-
Outcomes among valvular heart disease patients experiencing ischemic stroke or transient ischemic attack in Olmsted County, Minnesota.Mayo Clin Proc. 2005 Aug;80(8):1001-8. doi: 10.4065/80.8.1001. Mayo Clin Proc. 2005. PMID: 16092578
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
Risk of stroke with mitral valve prolapse in population-based cohort study.Stroke. 1995 Jan;26(1):7-13. doi: 10.1161/01.str.26.1.7. Stroke. 1995. PMID: 7839400
-
Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves.J Thorac Cardiovasc Surg. 2004 Jan;127(1):149-59. doi: 10.1016/j.jtcvs.2003.07.043. J Thorac Cardiovasc Surg. 2004. PMID: 14752425
-
[When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?].Presse Med. 2000 Nov 13;29(34):1867-75. Presse Med. 2000. PMID: 11709821 Review. French.
Cited by
-
Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.Bosn J Basic Med Sci. 2015 Jul 23;15(3):68-73. doi: 10.17305/bjbms.2015.503. Bosn J Basic Med Sci. 2015. PMID: 26295297 Free PMC article.
-
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.J Am Heart Assoc. 2016 Feb 18;5(2):e002776. doi: 10.1161/JAHA.115.002776. J Am Heart Assoc. 2016. PMID: 26892528 Free PMC article. Review. No abstract available.
-
Cerebral and Retinal Infarction in Bicuspid Aortic Valve.J Am Heart Assoc. 2023 Apr 4;12(7):e028789. doi: 10.1161/JAHA.122.028789. Epub 2023 Mar 21. J Am Heart Assoc. 2023. PMID: 36942747 Free PMC article.
-
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.Heart. 2016 Jul 1;102(13):1036-43. doi: 10.1136/heartjnl-2015-308120. Epub 2016 Feb 17. Heart. 2016. PMID: 26888572 Free PMC article. Clinical Trial.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30. J Am Coll Cardiol. 2024. PMID: 38043043 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical